Marinus Pharmaceuticals Stock News

RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #MarinusPharma--Marinus Pharmaceuticals to Present at Multiple Upcoming Investor Conferences

RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #MarinusPharma--Marinus Pharmaceuticals Reports Topline Ganaxolone Phase 2 Open-Label Results in Tuberous Sclerosis Complex and Receives FDA Orphan Drug Designat

Marinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q2 2021 Results - Earnings Call Transcript

RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #MarinusPharma--Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #MarinusPharma--Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercialization of Ganaxolone

RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #MarinusPharma--Marinus Pharmaceuticals Submits New Drug Application to FDA for Ganaxolone for the Treatment of Seizures Associated with CDKL5 Deficiency Disorde

BEST, JRSH, MRNS, MFGP and SABR have been added to the Zacks Rank #5 (Strong Sell) List on July 9, 2021.

RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS--MARINUS PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS--Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS--Marinus Pharmaceuticals to Present at Multiple Upcoming Investor Conferences.

ASLN, BLRX, FLXN, ICMB, and MRNS have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2021.

Marinus Pharmaceuticals, Inc. (MRNS) CEO Scott Braunstein on Q1 2021 Results - Earnings Call Transcript

Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of -60.87% and -30.67%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the sto

Shares of Marinus Pharmaceuticals (NASDAQ:MRNS) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share decreased 131.25% over the past year to ($0.74), which missed

RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #earnings--Marinus Pharmaceuticals Reschedules First Quarter 2021 Financial Results Conference Call for Monday, May 17 at 8:30 AM Eastern